14 September 2015
A new report by visiongain predicts that the world infusion pumps market will reach $8.09bn in 2015. This forecast and others appear in Infusion Pumps Market: Prospects for Leading Companies 2015-2025, published in October 2015. Visiongain is a business information provider based in London, UK.
Infusion pumps deliver fluids, nutrients, and medications such as antibiotics, chemotherapy drugs, and pain relievers, into a patient’s body in controlled amounts. Generally, they are used intravenously, but arterial, subcutaneous (beneath the skin), and epidural (just within the surface of the central nervous system) infusions are occasionally used. The leading segment within the market is the insulin infusion segment, driven by an increasing incidence of diabetes. While the number of diabetes patients is only set to grow, the infusion pumps market has remained significantly under-penetrated, leading visiongain to believe there will be a number of opportunities for success in the next decade. We estimate the total infusion pumps market worth to reach $8.09bn in 2015.
Maria Kercheva, a pharmaceutical and medical devices industry analyst in visiongain, said: “In 2013, diabetes affected 381.8million people while 175 million remained undiagnosed. Furthermore, it was estimated that around 10% of Type I and a very small proportion of Type II diabetics in the US use insulin infusion pumps as their main source of insulin. Those figures, combined with an increasing pump adoption, prevalence of chronic diseases and unmet needs for technological advances will serve as market growth drivers. A strong pipeline of investigational pumps and other systems is discussed in this report and will undoubtedly change the infusion pumps landscape once commercialised. Additionally, opportunities for medical devices companies continue arising, as patients demand safer and more-reliable treatment options. The next decade will see advances in all sub-segments of the market and will create opportunities for companies that are ready to offer technological advances in the field.”
Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a forecast of the global infusion pumps market through to 2025, as well as forecasts for three submarkets:
• Insulin pumps,
• Enteral feeding pumps
• Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)
National markets are also discussed, with forecasts to 2025 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and South Korea.
This independent, 206-page report guarantees you will remain better informed than your competition. With 128 tables and figures examining the infusion pumps market space, the report gives you a visual, one-stop breakdown of your market. In addition, this report provides analysis of competing technologies, with forecasts to 2025 for the global drug delivery technologies market and the following submarkets:
• Oral drug delivery
• Inhalation drug delivery
• Injectable/implantable drug delivery
• Transdermal drug delivery
• Ocular drug delivery
• Nasal drug delivery
Infusion Pumps Market: Prospects for Leading Companies 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on firstname.lastname@example.org
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.
01 December 2020
With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.
01 December 2020
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.